Amarpreet S. Sawhney, President and CEO, Ocular Therapeutix, Inc., Lexington, MA
Dr. Amarpreet S. Sawhney is the President and Chief Executive Officer (CEO) of Ocular Therapeutix, Inc., a company focused on unmet needs in ophthalmic surgical wound management and drug delivery. Previously, he was founder and CEO of Confluent Surgical; Chairman of MarketRx; technology founder of Focal, Inc. and Access Closure, Inc. He holds more than 120 patents, which form the basis for several first-of-a-kind medical devices that have helped millions of patients worldwide. He has founded six companies that account for over 1,600 jobs and more than $1.5 billion in revenue to date. Dr. Sawhney helps foster entrepreneurship by mentoring innovators and creating companies through Incept, a medical device incubator. He is a member of the board of directors of MassMedic, EcoSikh, Axtria, Ocular Therapeutix, Inc., Augmenix, and Incept LLC.
Dr. Sawhney was named one of the “Five Most Innovative Medical Device CEOs” by MassDevice in 2011. He has received several awards including the MassMedic Best Startup Company award, Frost & Sullivan Product Innovation award, MIT Global Indus Technovators award, and the Ernst & Young Regional Entrepreneur of the Year award. Dr. Sawhney holds a Ph.D. and M.S. in Chemical Engineering from the University of Texas at Austin and a B.Tech. in Chemical Engineering from IIT Delhi. He resides in Lexington, Massachusetts with his wife Deepika and two children Anhad and Pria.